---
figid: PMC9262990__41598_2022_15551_Fig14_HTML
figtitle: Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR
  pathway in Ehrlich breast cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC9262990
filename: 41598_2022_15551_Fig14_HTML.jpg
figlink: /pmc/articles/PMC9262990/figure/Fig14/
number: F14
caption: Shows the role of tumor-associated mast cells and their mediators (histamine,
  VEGF, and TNF-α) within the TME as well as the proposed mechanism of the anti-tumor
  effect of Cimetidine/Vitamin C by modulating mast cells mediators resulting in the
  restoring of oxidative stress balance, inhibition of angiogenesis and inactivation
  of PI3K/AKT/mTOR pathway leading to cancer cells apoptosis. TAMC tumour associated
  mast cell, TME tumour microenviroment, ROS reactive oxygen species, H2R histamine
  receptor 2, VEGF vascular endothelial growth factor, TNF-α tumour necrosis factor
  alpha, cAMP cyclic adenosine monophosphate, PKA protein kinase A, IRS-1 insulin
  receptor substrate-1, PI3K phosphatidylinositol-3-kinase, AKT serine/threonine kinase-1,
  m-TOR mammalian target of rapamycin.
papertitle: Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR
  pathway in Ehrlich breast cancer.
reftext: Sherihan Salaheldin Abdelhamid Ibrahim, et al. Sci Rep. 2022;12:11514.
year: '2022'
doi: 10.1038/s41598-022-15551-6
journal_title: Scientific Reports
journal_nlm_ta: Sci Rep
publisher_name: Nature Publishing Group UK
keywords: Biochemistry | Cancer | Immunology
automl_pathway: 0.9527865
figid_alias: PMC9262990__F14
figtype: Figure
redirect_from: /figures/PMC9262990__F14
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9262990__41598_2022_15551_Fig14_HTML.html
  '@type': Dataset
  description: Shows the role of tumor-associated mast cells and their mediators (histamine,
    VEGF, and TNF-α) within the TME as well as the proposed mechanism of the anti-tumor
    effect of Cimetidine/Vitamin C by modulating mast cells mediators resulting in
    the restoring of oxidative stress balance, inhibition of angiogenesis and inactivation
    of PI3K/AKT/mTOR pathway leading to cancer cells apoptosis. TAMC tumour associated
    mast cell, TME tumour microenviroment, ROS reactive oxygen species, H2R histamine
    receptor 2, VEGF vascular endothelial growth factor, TNF-α tumour necrosis factor
    alpha, cAMP cyclic adenosine monophosphate, PKA protein kinase A, IRS-1 insulin
    receptor substrate-1, PI3K phosphatidylinositol-3-kinase, AKT serine/threonine
    kinase-1, m-TOR mammalian target of rapamycin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MICE
  - WAS
  - HRH2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IRS1
  - TNF
  - H3P3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - Casp14
  - Was
  - Casp3
  - Hrh2
  - Vegfa
  - Irs1
  - Tnf
  - Akt1
  - Pik3r1
  - Mtor
  - Tme
  - Pik3cg
  - Kg
  - E(spl)mgamma-HLH
  - wac
  - 'On'
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Decay
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - egr
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tor
---
